The Pathophysiology of Gestational Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 163 of the 175 references it cites were found in a registry or an index; 42 of the 157 sources its claims cite were checked for support.
Abstract
Review of risk factors and maternal and child consequences of gestational diabetes mellitus.
Overview
CoChat Summary
TL;DR
This review summarizes the proposed pathophysiology of gestational diabetes mellitus (GDM), emphasizing that most cases involve β-cell dysfunction on a background of chronic insulin resistance. It argues that genetic, epigenetic, environmental, placental, inflammatory, oxidative, and microbiome-related factors likely interact, but the molecular mechanisms remain incompletely defined.
Key findings
- GDM affects approximately 14% of pregnancies worldwide according to 2017 IDF estimates, representing about 18 million births annually; the abstract also states approximately 16.5% worldwide.
- The review states that the vast majority (~80%) of GDM cases present as β-cell dysfunction on a background of chronic insulin resistance.
- In GDM, the rate of insulin-stimulated glucose uptake is reduced by 54% compared with normal pregnancy.
- The paper reports several outcome estimates: ~60% of women with prior GDM develop T2DM later in life, the yearly conversion risk is ~2 to 3%, and one study found a 63% increased risk of CVD among women with a history of GDM.
Methods
- This is a narrative review of the pathophysiology of GDM; it does not present a new experimental or clinical study.
- The paper synthesizes previously published evidence on glucose regulation in pregnancy, classification/prevalence, risk factors, consequences, and molecular mechanisms across tissues and systems.
- The analysis is descriptive and integrative, drawing on cited studies, including epidemiological studies, animal studies, mechanistic studies, and large cohort findings such as the HAPO Study (23,000 pregnant women).
Limitations
- The paper explicitly notes that epidemiological studies of risk factors for GDM are limited and typically afflicted by confounding factors, and that inconsistencies in diagnostic criteria and risk-factor measurement make studies hard to compare.
- The review states that molecular mechanisms underlying GDM are poorly defined and that greater understanding is required to develop effective treatments and prevention strategies.
- It is evident from the text that this is not an original empirical study, so it cannot establish causal effects on its own; it relies on secondary synthesis of heterogeneous prior literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
40 Valid · 2 Not valid · 86 Not checked · 24 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This loss of β-cell mass has been linked to epigenetic downregulation of pancreatic homeobox transcription factor (Pdx1), which is essential for normal β-cell differentiation in the embryo [79].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [79] Pinney, 2010, Epigenetic mechanisms in the development of type 2 diabetes, Trends Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The ‘Chromatin Remodeling in the β-cell of IUGR rats’ section reports epigenetic repression of Pdx-1 in growth-restricted rats and describes its critical role in pancreatic development and β-cell differentiation. It does not link that repression to a loss of β-cell mass; it instead discusses β-cell secretory dysfunction, and notes that a milder Pdx-1 reduction in mice permits normal β-cell mass. Page numbers were not available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [75] Prentki, 2006, Islet beta cell failure in type 2 diabetes, J. Clin. Investig. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) proposes that one or a small number of β-cell defects can become weak links when β-cells must compensate for insulin resistance. That supports the general idea of deficiencies becoming consequential under increased demand. The review-series passage mentioning pregnancy (page unavailable) instead discusses maternal hyperglycemia as a risk factor for the offspring; it does not say pregnancy exposes a pre-existing β-cell deficiency in the pregnant person. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, glucotoxicity is also thought to result in β-cell apoptosis over time [76].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Supportedcites [76] Ashcroft, 2017, Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells?, Cell MeTable source
The Abstract states that elevated plasma glucose leads to β-cell dysfunction and death and describes glycogen accumulation as contributing to this ‘glucotoxicity.’ The section ‘An Emerging Role for Glycogen in the Pathophysiology of Diabetes’ reports increased apoptosis in mouse β-cells with substantial glycogen stores. It qualifies the mechanism: apoptosis appears to result from glycogen accumulation rather than elevated glucose alone. Page numbers were not available in our copy. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“While potentially beneficial in times of famine, a mismatch between nutritional status in the womb and nutritional status once born can contribute to the development of obesity and metabolic disease [53,54].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Not checked — no full text of the sourcecites [53] Vickers, 2000, Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition, Am. J. Physiol. Endocrinol. MeTable source
- Supportedcites [54] Desai, 2014, Maternal obesity and high-fat diet program offspring metabolic syndrome, Am. J. Obstet. Gynecol. source
The Methods (The Offspring; page not provided) describe groups with different high-fat-diet exposures during pregnancy and lactation, including both mismatched combinations. The Discussion (page not provided) reports increased offspring adiposity or obesity and metabolic disturbances in these groups. This supports the attributed claim that a prenatal–postnatal nutritional mismatch can contribute to obesity and metabolic disease. (LLM, conf=0.90)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These individuals are more likely to have experienced hyperglycemia and β-cell fatigue even before birth, predisposing them to hyperglycemia during times of later metabolic stress, such as during pregnancy [55].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Partly supportedcites [55] Portha, B., Chavey, A., and Movassat, J. (2011). Early-Life Origins of Type 2 Diabetes: Fetal Programming of the Beta-Cell Mass. Exp. Diabetes Res., 2011. sourceExperimental — accuracy not yet measured
Section 4 (page unavailable) links early-life stressors, including maternal overnutrition, to later endocrine pancreatic deficiency and says pregnancy can expose a latent low insulin response in female offspring. It also describes hyperglycemia during fetal and/or early postnatal life. The copy does not establish that overnourished individuals experienced β-cell fatigue before birth; the discussion relies substantially on animal models and does not isolate prenatal exposure for every case. (LLM, conf=0.84)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 18 with their cited sources checked
Create a free account to see all 152 claims and to verify the 30 references still open.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 54
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An increased secretion of insulin-antagonistic hormones (placental hormones, cortisol) during pregnancy results in an increased insulin resistance, which, at the end of the third trimester, reaches a value similar to full-blown type 2 diabetes [9,42].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mechanisms of β-cell hypertrophy and proliferation, resulting in a 300% increase in insulin secretion in the first two trimesters of physiological pregnancy, is insufficient to explain GDM [9,39].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Despite numerous studies, the pathogenesis of GDM remains unclear, and the results obtained so far indicate a complex mechanism of interaction of many genetic, metabolic and environmental factors [9].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
In the citing paper
“Under GDM, maternal insulin resistance increases the flux of glucose to the fetal circulation and contributes to increased fetal glucose uptake and growth [8].”
From Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus (2019) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“In most cases, this hyperglycemia is the result of impaired glucose tolerance due to pancreatic β-cell dysfunction on a background of chronic insulin resistance.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 4. Conclusions
“in the majority of cases, pancreatic β-cells fail to compensate for a chronic fuel surfeit, leading to eventual insulin resistance, hyperglycemia, and an increased supply of glucose to the growing fetus.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“GDM affects approximately 16.5% of pregnancies worldwide, and this number is set to increase with the escalating obesity epidemic.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction
“According to the most recent (2017) International Diabetes Federation (IDF) estimates, GDM affects approximately 14% of pregnancies worldwide, representing approximately 18 million births annually [2].”
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Both red meat and animal protein decrease levels of Firmicutes, while high dietary fiber increase them [133].”
BackgroundChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“Increased gut permeability is thought to facilitate the movement of inflammatory mediators from the gut into the circulation, promoting systemic insulin resistance [134,136].”
BackgroundYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 1×
“Adiponectin enhances insulin signaling and fatty acid oxidation, and it inhibits gluconeogenesis [104].”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Non-diabetic obese individuals exhibit adequate adipose tissue expansion in response to fuel surfeit, and therefore maintain healthy blood glucose concentrations, sufficient β-cell compensation, and avoid chronic insulin resistance [110,111].”
Background
Research works printed but not linked: 1
- Halliwell, B., and Gutteridge, J. (2007). Free Radicals in Biology and Medicine, Oxford University Press. [4th ed.].
Cited by
Items 1,201–1,300 of 1,810
Zhang, P., Ding, C. Q., Wang, Y., Du, P., & Tian, M.-L. (2025) · CytoJournal · doi:10.25259/cytojournal_182_2024 · Cited by 3
“[2] GDM is recognized as a multifactorial condition, with significant contributions from internal genetic and external environmental factors.”
Evidence for early treatment of hyperglycemia in pregnancy
Lim, V. (2026) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2026.102096 · Cited by 1
Increased fetal epicardial fat thickness; a reflecting finding for GDM and perinatal outcomesPreprint
Yakut, K., İskender, C., Dereli, M. L., Sağlam, E., Çelen, Ş., Çağlar, A. T., & Üstün, Y. E. (2022) · doi:10.22541/au.164854998.87830673/v1 · Cited by 1
Özer, S., Baylan, F. A., & Tok, A. (2023) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2022-0097 · Cited by 2
“Although prevalence has been reported as 7 – 16.5 %, it varies from community to community according to the diagnostic test and diagnostic criteria used [2, 3].”
BackgroundInfluentialEnhancing Maternal Health: A Soft Computing Approach to Pregnancy Risk Management
Shedge, P. P., Mehta, P. S., Vyavahare, S., & Rupnar, V. (2024) · Advances in medical technologies and clinical practice book series · doi:10.4018/979-8-3693-3711-0.ch004 · Cited by 1
Ji, Q., Liu, H., Wang, F., et al. (2024) · AME Case Reports · doi:10.21037/acr-24-52 · Cited by 1
“Both GDM and overt diabetes diagnosed in pregnancy occur due to the increased insulin resistance caused by insulin-antagonizing hormones secreted by adipocytes and placental tissues after pregnancy, the low-level inflammatory responses, and the reduced sensitivity to insulin of pregnant women (8).”
BackgroundHeague, M., Henney, A. E., Riley, D. R. J., Anson, M., Meek, C. L., Alam, U., & Cuthbertson, D. J. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113171 · Cited by 1
Li, X., Bu, W., Hu, X., Han, T., & Xuan, Y. (2024) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/j.ijporl.2024.112056 · Cited by 4
Sun, J., Liu, L., Shen, J., & Du, J. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02045-5 · Cited by 2
Coelho, S., Borges‐Canha, M., Leite, A. R., Neves, J. S., Oliveira, A. I., Carvalho, D. M., Diabetes and Pregnancy Study Group of the Portuguese Society of Diabetology, & Ameida, M. D. C. (2023) · Endocrine · doi:10.1007/s12020-023-03441-4 · Cited by 1
“…including maternal overweight and obesity, excessive gestational weight gain (GWG), advanced maternal age, westernized diet, micronutrient de fi ciencies, family and personal history of GDM, as well as other diseases related to insulin resistance, such as polycystic ovarian syndrome (PCOS) [4, 7].”
BackgroundMethodInfluentialScreening for Gestational Diabetes; Can Apelin Help?
Salman, D. A., Hussein, Z. A., Eimad, T., & Nori, W. (2023) · Current Women s Health Reviews · doi:10.2174/1573404819666230206102810 · Cited by 1
TERAPIA NUTRICIONAL EM PACIENTES ONCOLÓGICOS
da Cruz, L. P. L., Neto, J. G. D. O., Nascimento, W. S. M., Oliveira, A. C. V., Muniz, T. L., Silva, E. C. M. M., de Aragão, M. A. F., Sales, P. L. P., dos Santos, N. C., dos Santos, W. R., et al. (2023) · doi:10.56161/sci.ed.20230900c6 · Cited by 1
Long-Term Maternal Complications
Kakotrichi, P., Mantsiou, C. D., Bekiari, E., & Τσάπας, Α. (2022) · Springer eBooks · doi:10.1007/978-3-030-89243-2_19 · Cited by 1
Pang, Q., Peng, L., Wu, J., Wang, Y., Zhang, R., Liu, Z., & Jiang, L. (2026) · International Journal of Women s Health · doi:10.2147/ijwh.s541610 · Cited by 3
“11,12 Although current prediction models based on clinical parameters achieve only modest sensitivity (51.5”
InfluentialMacrossomia fetal e o risco de obesidade infantil
de Oliveira, R. M. A., Lira, J. L. M., Amorim, D. S., Calado, M. F., Santos, W. D. J., Fernandes, F. N., Moreira, R. D. S., Lima, F. L. O., de Siqueira, E. A. S., & Oliveira, L. D. L. (2022) · Research Society and Development · doi:10.33448/rsd-v11i7.29572 · Cited by 1
Balasubramaniyam, S., Rathinam, T., Srinivasan, M., & Himayavendhan, H. V. (2026) · Biomedical Materials & Devices · doi:10.1007/s44174-026-00643-y · Cited by 1
Inter-Relationships of Pediatric Obesity and Mitochondrial Dysfunction
Saad, R. A., & Qutob, H. M. H. (2023) · International Electronic Conference on Biomedicines (IECBM) · doi:10.3390/ecb2023-14336 · Cited by 2
“While GDM normally subsides after delivery, it can have long-term health implications for the mother, such as an increased risk of type 2 diabetes (T2DM) and cardiovascular disease (CVD) as well as future obesity, CVD, T2DM, and/or GDM for the child [25].”
BackgroundKöse, O., Gök, K., Köse, E., Gözükara, S. I., Tüten, A., & Bostancı, M. S. (2025) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/ceog26541 · Cited by 1
Parto a termo precoce em mulheres com gestação complicada por diabetes e hipoglicemia neonatal
Camargo, S. F., Neto, J. D. C. L., Camargo, J. D. D. A. S., & Cornetta, M. D. C. D. M. (2020) · Saúde e Pesquisa · doi:10.17765/2176-9206.2020v13n3p645-652 · Cited by 1
Molecular mechanisms of insulin resistance in normal pregnancy and gestational diabetes
Zhuravlyova, L., Sokolnikova, N. V., & Rogachova, T. (2021) · Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini · doi:10.15407/internalmed2021.01.022 · Cited by 1
Lin, L., Dong, J., Wang, Y., Song, L., Ye, X., Chen, X., Miao, C., & Lin, J. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-077336 · Cited by 4
Tu, M., Sun, G., Wu, M. C., Cao, X., Zhang, X., Tan, T., Zhong, C., Huang, L., Chen, R., Zhou, X., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1334495/v1 · Cited by 1
Wulaningsih, I., Hapsari, E. D., Pangastuti, H. S., & Priharjo, R. (2020) · Jurnal NERS · doi:10.20473/jn.v15i2.19306 · Cited by 3
“Mother insulin cannot reach the fetus, so the mother's blood sugar levels affect fetal blood levels (Alia et al., 2019; Plows et al., 2018).”
BackgroundBahramfard, T., Zolghadrpour, M.-A., Jowshan, M.-R., Sheikhi, D., Zandvakili, A., Mohagheghzade, Z., Roozbehi, M., & Pourmahmoudi, A. (2025) · BMC Nutrition · doi:10.1186/s40795-025-01070-w · Cited by 2
“In particular, proinflammatory cytokines are one such factor [30].”
InfluentialLiang, C., Lu, Y. E., Luo, X., & Weng, F. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s474453 · Cited by 3
“12 In patients with GDM, key immune defenses are impaired, increasing SSI susceptibility.”
BackgroundMetabolomic and Proteomic Profiling of Women with Gestational Diabetes Mellitus
Rzewuska, A., & Gęca, T. (2026) · Nutrients · doi:10.3390/nu18121971 · Cited by 1
“In the long term, it is also linked to the development of type 2 diabetes and cardiovascular diseases in mothers, as well as metabolic disorders in chil-dren [3].”
Tran, N. K., Cao, N. T., Pham, L. V., Lam, T. D., Vo, T., Nguyen, T. T., Nguyen, N. N., Chau, D. H., & Nguyen, B. T. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-08249-w · Cited by 2
“Pre-pregnancy overweight/obesity exacerbates insulin resistance [23–25], increasing GDM risk by 2.6-fold globally, up to 3.27-fold in Asians [26–29], and 1.6-fold in Vietnamese women [5].”
InfluentialGutiérrez, E. G., & Quintana, J. A. (2023) · doi:10.29393/tdudec-28md1de28 · Cited by 2
Daraie, M., Rad, H. A., Amiri, F. N., Faramarzi, M., Gholinia, H., & Darzi, S. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07605-6 · Cited by 1
“According to the latest estimates by the International Diabetes Federation (IDF), gestational diabetes affects about 1 to 14% of pregnancies worldwide [7].”
Delgado, A., & Louis, J. M. (2024) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2024.08.001 · Cited by 1
Longer Interpregnancy Interval Is Associated with Gestational Diabetes Mellitus Recurrence
Peled, T., Federmesser, D., Mazaki, E., Sela, H. Y., Grisaru‐Granovsky, S., & Rottenstreich, M. (2024) · American Journal of Perinatology · doi:10.1055/a-2480-5407 · Cited by 1
Veretekhina, T. V., St. Petersburg, R. F., & Yarmolinskaya, M. I. (2024) · Women s Health and Reproduction · doi:10.31550/2712-8598-2024-1-1-zhzir · Cited by 1
Wei, L., Zhou, X., Zhu, S., Li, J., Zeng, Y., Yu, J., Wang, S., & Feng, L. (2019) · Maternal-Fetal Medicine · doi:10.1097/fm9.0000000000000030 · Cited by 1
Rezende, G. D. O., Bezerra, A. P. S., Crespo, R. C. L., & Oliveira, V. B. D. (2023) · Revista Foco · doi:10.54751/revistafoco.v16n10-082 · Cited by 1
Rosales-Gómez, C., Martínez‐Carrillo, B. E., López, A. L. G., Reséndiz‐Albor, A. A., Arciniega-Martínez, I. M., & Aguilar-Rodríguez, E. (2025) · Life · doi:10.3390/life15070989 · Cited by 1
“This metabolic condition leads to an elevated risk of comorbidities for both mother and fetus [35].”
The role of 25(OH)D3 levels in gestational diabetes and its outcomes
Zhang, M., Ning, J., Gao, L., Guo, H., Liu, W., & Fan, X. (2025) · Medicine · doi:10.1097/md.0000000000043430 · Cited by 1
“[10] Therefore, early screening, prevention, and treatment of GDM are crucial for ensuring maternal and infant health.”
Malar, S. T., Meenakshi, S., Chandrasekar, A., & Amritkumar, P. (2025) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-025-01562-2 · Cited by 1
The association between Lifelines Diet Score and GDM: a case-control study
Abudari, M. O., Alreshidi, N. F., Alharbi, S. S., Al-Ziyadi, S. H., Alanazi, M. A., Kambal, N., Elmansy, F. M., & Elbqry, M. G. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1625903 · Cited by 1
“Several factors, such as increasing maternal age and increasing rates of obesity, as well as sedentary lifestyles, have been attributed to the increasing prevalence of GDM (3).”
Russkova, N. E., Shumak, A. V., & Владимировна, Т. Е. (2021) · V F Snegirev Archives of Obstetrics and Gynecology · doi:10.17816/2313-8726-2021-8-4-207-212 · Cited by 1
Moore, A., Astbury, N., Poduval, S., & Ross, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3256059/v1 · Cited by 1
Shojaei‐Zarghani, S., Naziri, Z., Nasr, M., Rostamian, F., Mokhtari, Z., & Kazemi, A. (2026) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2026.103398 · Cited by 1
Nasiri, M., Mousavi, S. N., Rad, Z. A., & Heidarzadeh, S. (2025) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-025-01491-0 · Cited by 1
“Therefore, the mother becomes hyperglycemic [25].”
Artificial Intelligence for Predicting Pregnancy Risk Factors: A Literature Review
Lakhdadi, K., Boujraine, K., & Satori, H. (2025) · International Conference on Embedded Systems and Artificial Intelligence (ESAI) · doi:10.1109/esai67033.2025.11438364 · Cited by 1
“We consider this problem a significant risk factor for hypertensive disorders and preeclampsia [17].”
Suissa, N., Badeghiesh, A. M., Baghlaf, H. A., & Dahan, M. H. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07861-z · Cited by 1
“This leads to impaired glucose regulation, leading to gestational diabetes [26].”
Allehyani, R. F., Alsehli, A. A., Saggat, R. Z., Aldurdunji, M. M., & Alorfi, N. M. (2025) · Medicine · doi:10.1097/md.0000000000041322 · Cited by 2
Weningtyas, A., Aninditha, D., Putri, S. N. A., Erdianto, W. P., Khotimah, H., Kalsum, U., Rahayu, M., Handayani, D., & Kurniawan, S. N. (2023) · AIP conference proceedings · doi:10.1063/5.0111217 · Cited by 1
Histochemical Study of Human Placental Tissues in Gestational Diabetic Mellitus
Lafta, I. A., Abdulhameed, W. A., & Al-Bakri, N. A. (2021) · Iraqi Journal of Embryos and Infertility Researches · doi:10.28969/ijeir.v11.i2.r3 · Cited by 1
Isyti’aroh, I., Sugiharto, S., Rofiqoh, S., et al. (2023) · Jurnal Ilmiah Kesehatan Keperawatan · doi:10.26753/jikk.v19i1.1088 · Cited by 1
Hallack, C., Nogueira, B. V., Bomfim, M. D. L., Meireles, N. G., & Martins, W. P. (2026) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.61622/rbgo/2026rbgo18 · Cited by 1
Ribeiro, T. D. C., Rodrigues, R. D., Vitorino, A. L. D. S., da Silva, A. G., Chaves, M. M. G., de Freitas, G. L., & Moreira, A. D. (2026) · Revista gaúcha de enfermagem · doi:10.1590/1983-1447.2026.20250179.pt · Cited by 2
Chen, X., Zhang, Y., Tang, Y., Sun, X., Tong, J., & Yan, D. (2023) · Journal of Public Health · doi:10.1007/s10389-023-02042-9 · Cited by 2
“GDM also increases the risk of type 2 diabetes and cardiovascular disease in the mother, as well as the likelihood of future obesity in the child (Plows et al. 2018; Szmuilowicz et al. 2019).”
Meta Analysis the Effect of Gestational Diabetes Mellitus on Macrosomia and Sectio Caesarea
Ratna, T. Y., Dewi, Y. L. R., & Murti, B. (2021) · Journal of Maternal and Child Health · doi:10.26911/thejmch.2021.06.03.12 · Cited by 3
Challenges in the management of gestational diabetes mellitus in anorexia nervosa
Siddiqui, R., & McAdams, C. J. (2024) · Psychiatry Research Case Reports · doi:10.1016/j.psycr.2024.100215 · Cited by 2
Gestational diabetes mellitus dysregulates the PD-1/PD-L1 axis at the feto-maternal interfacePreprint
Mihalic, Z., Kindler, O., Raftopoulou, S., Santiso, A., Wadsack, C., Heinemann, Á., & Kargl, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.25.525478 · Cited by 2
Arabain, S.-A. (2025) · SOCIAL PSYCHOLOGY AND HUMAN EXPERIENCE · doi:10.62596/qdhd1q07 · Cited by 1
Gestasyonel Diyabetes Mellitusun Emzirme ve Doğum Sonu Dönem Üzerine Etkisi
KINIK, E., Yılmaz, T., Kaya, H. D., & Günaydın, S. (2023) · KTO Karatay Üniversitesi Sağlık Bilimleri Dergisi · doi:10.59244/ktokusbd.1263478 · Cited by 2
Beernink, R. H. J., & Schuitemaker, J. H. N. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_33 · Cited by 2
Sharma, A. K., Mohan, L., Mittal, S., Bahadur, A., Mirza, A. A., & Thapiyal, M. (2023) · Cureus · doi:10.7759/cureus.49619 · Cited by 3
“This can be due to improvement in glycemic status after removal of hormonal influences involved in increasing IR during pregnancy [27].”
BackgroundImpact of Gestational Diabetes on Neonatal Birth Weight and Maternal Postpartum Metabolic Changes
Khan, A. A., Javed, S., Noreen, S., Chaudhry, M. R., & Afridi, S. (2025) · Cureus · doi:10.7759/cureus.86060 · Cited by 8
“Gestational diabetes mellitus (GDM) is a glucose intolerance that arises during pregnancy, affecting approximately 7-14% of pregnancies globally, with even higher rates in South Asia [1,2].”
Ивановна, А. Е., Yarmolinskaya, M. I., & Osinovskaya, N. S. (2023) · Journal of obstetrics and women s diseases · doi:10.17816/jowd611015 · Cited by 2
Yang, X., Jiang, R., Wang, G., Zhao, N., Yin, X., & Li, C. (2026) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2026.2621484 · Cited by 1
Li, W., Jiang, S., Xie, H., & Tong, L. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1749694 · Cited by 1
de Souza, L. B. A., Luna, L. D. S., Montero, M. F., de Souza, F. D., Jordão, M. C., Abate, M. C. M. D. O., Mattar, R., Dib, S. A., Dualib, P. M., & de Almeida-Pititto, B. (2025) · Revista Paulista de Pediatria · doi:10.1590/1984-0462/2025/43/2025131 · Cited by 1
Minami, M., Watanabe, T., Eitoku, M., Maeda, N., Fujieda, M., Suganuma, N., & the Japan Environment and Children’s Study (JECS) Group (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01294-2 · Cited by 2
“Even if blood glucose levels return to normal after delivery, diabetes can easily develop in older women [6].”
BackgroundZhou, Y., Lan, Q., & Qi, L. (2025) · Pregnancy Hypertension · doi:10.1016/j.preghy.2025.101248 · Cited by 2
Karcz, K., Gaweł, P., & Królak‐Olejnik, B. (2024) · Nutrients · doi:10.3390/nu16223871 · Cited by 2
“The prevalence of GDM is constantly increasing with the escalating obesity epidemic, which is fueled by poor dietary habits and sedentary lifestyles [3].”
Li, Q., Chen, J., Wang, Z., Li, Z., Yu, Z., & Yang, D. (2025) · Physiological Research · doi:10.33549/physiolres.935474 · Cited by 1
“Gestational diabetes (GD) is a type of diabetes, in sulin resistance occur at the time of pregnancy, higher prevalence rate with mortality [1].”
Bhatta, L., Bond, T. A., Warrington, N. M., Wang, G., Denos, M., Evans, D. M., Lawlor, D. A., Åsvold, B. O., Moen, G.-H., & Brumpton, B. M. (2025) · medRxiv · doi:10.1101/2025.05.07.25326949 · Cited by 2
“This is seen, for example in gestational diabetes, where mothers are unable to compensate with insulin for the increase in circulating glucose naturally occurring in pregnancy, resulting in maternal hyperglycemia and excess fetal growth 2 3 .”
Jagriti, J., Prabhat, P., Jain, A., Saxena, P., & Kumar, A. A. (2024) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2024-0040 · Cited by 2
Cardiometabolic Risks in Gestational Diabetes Mellitus: A Mini-Review
Renugasundari, M., Pal, G. K., Chaturvedula, L., Nanda, N., & Harichandrakumar, K. (2022) · International Journal of Clinical and Experimental Physiology · doi:10.5530/ijcep.2022.9.2.16 · Cited by 1
Zhang, R., Garstka, M. A., Zhang, C., Ding, S., & Xu, J. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70048 · Cited by 1
“It may be because diabetes and GDM include more pathologies than IR, such as islet b -cell dysfunction 28, 61 .”
El-Farrash, R. A., Ismail, E. A. R., Nada, A. S., & Elesnawy, K. Y. (2024) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2024.06.016 · Cited by 1
Zhao, D., Yuan, N., Zhao, X., Sun, J., Xu, X., & Zhang, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1596717 · Cited by 1
Pereira, A. P., Montero, M. F., de Souza, F. D., Jordão, M. C., Oliveira, M. C. M., Mattar, R., Dib, S. A., Dualib, P. M., & de Almeida-Pititto, B. (2024) · Cureus · doi:10.7759/cureus.65546 · Cited by 4
Nurses’ Role in Taking Care of Gestational Diabetes Mellitus Patients: A Qualitative Study
Pujiyanto, T. I., & Wulaningsih, I. (2021) · Jurnal NERS · doi:10.20473/jn.v16i2.29811 · Cited by 1
“in pancreatic ß cell function is a consistent finding in women with prior GDM (Buchanan et al., 2012; Plows et al., 2018).”
BackgroundRachna, Sharma, R., Baranwal, N., & Tuteja, M. (2025) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20250202 · Cited by 1
Sweet Spot Regulation of Maternal Metabolic Health and Nutrition on β-Cell Mass in the Offspring
Chung, G., Wong, A., Her, T. K., & Alejandro, E. U. (2024) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-031-62232-8_7 · Cited by 1
Does gestational diabetes mellitus influence the morphological characteristics of the placenta?
de Souza, D. G., Menezes, L. S., de Macedo, T. E., Oliveira, G. R., Brandão, V. P., Martins, M. D. N., Costa, N. B. M., da Silva, F. D. M., Morais, J. A. V., & Pacheco, T. J. A. (2022) · Research Society and Development · doi:10.33448/rsd-v11i3.26851 · Cited by 1
“…micronutrient deficiencies, endocrine dysfunction, advanced maternal age and family history of diabetes, which can influence changes in blood glucose levels, resulting in chronic hyperglycemia during the pregnancy (American Diabetes Association, 2020; Plows et al., 2018; Zaugg et al., 2020).”
BackgroundInsulin resistance and its role in the pathogenesis of pre-diabetes development in obese adolescents
Minkova, N. B., Latyshev, O. Y., Okminyan, G., Kiseleva, E., Сергеевна, Р. Д., & Самсонова, Л. Н. (2023) · Consilium Medicum · doi:10.26442/20751753.2023.8.202342 · Cited by 2
Kang, Y. E., Lee, S. E., Lim, J. Y., Kim, O. S., Yoon, J., Jung, Y., Lee, J. H., Ku, B. J., Lee, M., & Kim, H. J. (2026) · Medicine · doi:10.1097/md.0000000000048747 · Cited by 1
“[9] During pregnancy, the placenta secretes hormones such as human placental lactogen and placental growth hormone, which increase insulin resistance in maternal tissues to ensure adequate glucose availability for the fetus.”
Cheng, Y., Ding, W., Zhang, Y., Wang, H., Zhu, X., & Xu, X. (2025) · Healthcare and Rehabilitation · doi:10.1016/j.hcr.2025.100020 · Cited by 3
Dy, K., & Yao, C. (2022) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.037.02.05 · Cited by 1
Vasilj, O., Mišković, B., & Stanojevic, M. (2026) · Donald School Journal of Ultrasound in Obstetrics & Gynecology · doi:10.5005/jp-journals-10009-2105 · Cited by 1
Ferroptosis and Its Emerging Role in Gestational Diabetes Mellitus
Xu, J., Tian, Y., Zhu, H., Peng, B., & Mo, C. (2026) · Medicine Advances · doi:10.1002/med4.70055 · Cited by 5
“Although various mechanisms, such as lipotoxicity, inflammation, enhanced gluconeogenesis, and oxidative stress, have been implicated [16–18], the exact pathogenesis of GDM remains incompletely understood.”
Heart Rate Variability in Newborns From Diabetic Mothers: Clinical Application and Significance
Beretta, V., Cannavò, L., Ravenda, S., Petrolini, C., Raitano, V., Moretti, S., Dell’Orto, V., & Perrone, S. (2026) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.70173 · Cited by 1
“In Italy, in 2021, GDM affected 14.3% of pregnancies, with an estimated 40,000 cases annually out of 400,000 pregnancies (Plows et al. 2018).”
InfluentialWu, Y., Asvadi, S., van der Ven, M., der Jagt, M. B. V. D. H., Peri, E., Fonseca, P. M., Overeem, S., Oei, S. G., Mischi, M., & Long, X. (2025) · npj Women s Health · doi:10.1038/s44294-025-00081-z · Cited by 2
“In the second trimester, as pregnancy progresses, surges in local and placental hormones, including estrogen, progesterone, leptin, cortisol, placental lac-togen,andplacentalgrowthhormone,combinetopromoteastateofinsulin resistance 17 .”
Feroz, N., Imtiaz, F., Siddiqui, S., et al. (2024) · Journal of the Pakistan Medical Association · doi:10.47391/jpma-duhs-s06 · Cited by 1
Khalid, S. (2021) · DIET FACTOR (Journal of Nutritional & Food Sciences) · doi:10.54393/df.v2i02.18 · Cited by 6
Gestational age and models for predicting gestational diabetes mellitus
Murphy, A. M., GORNBEIN, J. A., Yin, O., & Koos, B. J. (2025) · Metabolomics · doi:10.1007/s11306-025-02314-3 · Cited by 3
“(Lee et al., 2018; Perry et al., 2015; Pinto et al., 2023; Plows et al., 2018; Usman et al., 2023).”
Kalaij, A. G. I., Dyson, N. G., & Sugiyanto, M. (2021) · Journal of Asian Medical Students Association · doi:10.52629/jamsa.v9i1.260 · Cited by 1
“glucose level and free fatty acids concentration.(18) However, the increased degree of insulin resistance or impaired compensatory pancreatic β-cells hyperplasia can result in gestational diabetes mellitus.”
BackgroundInfluentialTyagi, S., & Mani, S. (2023) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/0118715257261643231018102928 · Cited by 2
van Hoorn, E. G. M., Prins, J. R., Koning, S. H., ERWICH, J. J. H. M., Lutgers, H. L., Kooy, A., Wolffenbuttel, B. H. R., van Dijk, P. R., & Hoogenberg, K. (2026) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2026.2680351 · Cited by 1
Positive Airway Pressure Therapy for Obstructive Sleep Apnea in High‐Risk Pregnancy: A Meta‐Analysis
Cabral, T. D. D., Knoll, R. M., Plane, J., Viana, P., Vendramini, B. D. V., Conrado, J. E. P., Caruso, V., & Huyett, P. A. (2025) · The Laryngoscope · doi:10.1002/lary.70009 · Cited by 1
“Given the distinct metabolic demands of pregnancy and the pathophysiology of gestational diabetes [63], longer treatment may be necessary to observe meaningful changes in gestational diabetes.”
Ntshauba, E. T., Maimela, E., Ntuli, T. S., & Mamogobo, P. M. (2025) · BMC Public Health · doi:10.1186/s12889-025-25099-5 · Cited by 1
“…of gestational diabetes and these include obesity, a westernised diet, ethnicity, advanced maternal age, the intrauterine environment (low or high birth weight), a family history of diabetes, excessive gestational weight gain, polycystic ovarian syndrome (PCOS) and genetic polymorphisms [5].”
Golshan-Tafti, M., Aarafi, H., Hajizadeh, N., Dastgheib, S. A., Bahrami, R., Karimi‐Zarchi, M., Aghasipour, M., Abbasi, H., Azizi, S., Shiri, A., et al. (2023) · World Journal of Peri & Neonatology · doi:10.18502/wjpn.v6i1.14250 · Cited by 2
Hamdan, H. Z. (2025) · PubMed Central · Cited by 2
Shamarakova, M. V., Nizyaeva, N. V., Zayratyants, G. O., Boltovskaya, M. N., Артемьева, К. А., Аксенова, М. Г., Bochkov, V. V., Dobrokhotova, Y. E., & Михалева, Л. М. (2024) · CLINICAL AND EXPERIMENTAL MORPHOLOGY · doi:10.31088/cem2024.13.2.5-13 · Cited by 1
Shehzad, S., Shabbir, N. A., Mumtaz, M., Um-A-Aiman, Shaheen, M. A., Umer, M. R., & Sahar, A. (2025) · Cureus · doi:10.7759/cureus.89238 · Cited by 5
Yang, X. M., Song, Y., Wang, Y., Zhang, J., Huang, H., Zhang, J., Han, R., Xiang, Z., Chen, L., & Gao, L. (2025) · International Journal of Nursing Practice · doi:10.1111/ijn.70013 · Cited by 2
Metadata
- Authors
- Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H.
- Affiliations
- University of Southern California (US)
- University of Auckland (NZ)
- University of Leicester (GB)
- Corresponding author
- Vickers, Mark H
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-10-26
- Volume
- 19
- Issue
- 11
- Pages
- 3342
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6274679
- OpenAlex
- W2898266729
- Cited by
- 1,874
- References
- 175
- Citations by year
- 2026: 277 · 2025: 298 · 2024: 319 · 2023: 307 · 2022: 295 · 2021: 221 · 2020: 122 · 2019: 33
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- gestational diabetes mellitus, pathophysiology, hyperglycemia in pregnancy, impaired glucose tolerance, beta-cell dysfunction, insulin resistance, maternal obesity, type 2 diabetes risk, macrosomia, cardiovascular risk, GDM prevention, insulin therapy, lifestyle intervention
- MeSH terms
- Adipose Tissue, Animals, Female, Glucose, Humans, Insulin Resistance, Pregnancy, Risk Factors, Diabetes, Gestational, Oxidative Stress, Leptin, Insulin-Secreting Cells, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.